http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020246254-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545302b240d6b35a027dc33ff7289a4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d201a88fcd3ba40eadb6918291094f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c19b908ecec437500096fc905e3b60
publicationDate 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020246254-A1
titleOfInvention Parenteral dosage form of diltiazem
abstract The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113476411-A
priorityDate 2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13020083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415790436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419867546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID358939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415952184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226915878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449307707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44659717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57339259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451610230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 59.